Quantifying prevalence and risk factors of HIV multiple infection in Uganda from population-based deep-sequence data.
Martin MA. et al, (2025), PLoS pathogens, 21
A putative hepatitis B virus sequence motif associated with hepatocellular carcinoma in South African adults
Maponga TG. et al, (2025), Annals of Hepatology, 101763 - 101763
Castanet: a pipeline for rapid analysis of targeted multi-pathogen genomic data.
Mayne R. et al, (2024), Bioinformatics (Oxford, England), 40
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
HIV transmission dynamics and population-wide drug resistance in rural South Africa.
Kemp SA. et al, (2024), Nature communications, 15
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus
Lin G-L. et al, (2024), Nature Communications, 15
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Wei J. et al, (2024), Nature Communications, 15
Intra- and inter-subtype HIV diversity between 1994 and 2018 in southern Uganda: a longitudinal population-based study.
Kim S. et al, (2024), Virus evolution, 10
Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study.
Hall M. et al, (2023), The Lancet. Microbe
Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda.
Monod M. et al, (2023), Nature microbiology
Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length Genomes.
Christensen KT. et al, (2023), Viruses, 15
Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory.
Jenkins F. et al, (2023), Journal of medical virology, 95
Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey
Lythgoe KA. et al, (2023), Proceedings of the Royal Society B: Biological Sciences, 290
Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort.
Abdullahi A. et al, (2023), The Journal of antimicrobial chemotherapy, 78, 2000 - 2007
COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK
Buckell J. et al, (2023), Scientific Reports, 13
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Wei J. et al, (2023), Nature Communications, 14
Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes
Cotton S. et al, (2023), Journal of Hospital Infection, 135, 28 - 36
The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis.
Pascall DJ. et al, (2023), PloS one, 18
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
Kläser K. et al, (2022), Scientific Reports, 12
Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning
Nickbakhsh S. et al, (2022), Scientific Reports, 12
The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA
Zhao L. et al, (2022), Proceedings of the Royal Society B: Biological Sciences, 289
Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Willett BJ. et al, (2022), Nature Microbiology, 7, 1709 - 1709
Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort.
Christensen KT. et al, (2022), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 155
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Vihta1 KD. et al, (2022), Clinical Infectious Diseases
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Willett BJ. et al, (2022), Nature Microbiology, 7, 1161 - 1179
Recurrent SARS-CoV-2 mutations in immunodeficient patients.
Wilkinson SAJ. et al, (2022), Virus evolution, 8
SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2.
Eales O. et al, (2022), BMC infectious diseases, 22
Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021.
Smallman-Raynor MR. et al, (2022), Epidemiology and infection, 150
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
Wei J. et al, (2022), Nature Communications, 13
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Wei J. et al, (2022), Nature Medicine, 28, 1072 - 1082
Tracking SARS-CoV-2 Mutations & Variants Through the COG-UK-Mutation Explorer
Wright DW. et al, (2022), Virus Evolution
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Wei J. et al, (2022), Nature Medicine
Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission.
Aggarwal D. et al, (2022), Nature communications, 13
Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic.
Jackson B. et al, (2021), Cell, 184, 5179 - 5188.e8
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Thomson EC. et al, (2021), Cell, 184, 1171 - 1187.e20